Bausch + Lomb has announced that it has bought some of the assets and intellectual property of Miochol, a drug used during eye surgery to constrict the pupil. Affiliates of Novartis sold the assets, and will provide technical assistance to B+L during the transition period. B+L has the assets for ...
Buying a membership today will give you:
To continue reading this article register now.